GL1X · GenesisL1 explorer

MolNFT v1 · #165668 · protein

PCSK9 in complex with compound 5

6U2P · Proprotein convertase SUBTILISIN/KEXIN type 9: “PCSK9 in complex with compound 5”. X-ray diffraction, 1 ligand (PUV), 6 pockets (best druggability 0.74). MolNFT v1 #165668 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6U2P
Type
protein
Length
573 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proprotein convertase SUBTILISIN/KEXIN type 9
EC
3.4.21.-
UniProt
Q8NBP7
Ligands
PUV
Pockets
6 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 19% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein9228% helix, 39% strandQ8NBP7
BProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein48117% helix, 40% strandQ8NBP7

Ligands and binding sites

  • PUV · 2-fluoro-4-{[(1R)-6-methoxy-1-methyl-1-{2-oxo-2-[(1,3-thiazol-2-yl)amino]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}benzoic acid · ligand · chains B
  • EDO · 1,2-ethanediol · additive · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15450.740.8263PUV
23240.730.8549empty
3580.370.8017empty
4970.360.7419empty
5560.330.7716empty

Interfaces

1 interface between chains.

  • A–B · 1410 Ų buried · 27 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide (disulfide).

Compared structures

  • 6U2P · PCSK9 in complex with compound 5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.